Tag: analyzer

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

ACTON, Mass., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX) (“Bluejay” or the “Company”), a medical diagnostics company developing near-patient solutions for critical care, today announced financial results for the quarter ended June 30, 2025, and provided an update on its Symphony IL-6 test program and key operational milestones.

Pason Reports Second Quarter 2025 Results and Declares Quarterly Dividend

CALGARY, AB, Aug. 6, 2025 /CNW/ - Pason Systems Inc. ("Pason" or the "Company") (TSX: PSI) (OTC: PSYTF) announced today its 2025 second quarter...

US Air Force Awards Gastops $18.6M Contract for ChipCHECK Oil Debris Analyzers

HUNTSVILLE, Ala., Aug. 6, 2025 /PRNewswire/ -- Gastops USA has been awarded an $18.6 million follow-on contract by the U.S. Air Force to supply its...

Biomarkers Market to Grow at a CAGR of 12.3% from 2025 to 2032 | SkyQuest Technology Consulting

The Biomarkers Market is anticipated to expand at a rapid pace due to the increasing demand for personalized medicine, rising prevalence of chronic and...

FINAL CESIUM TEST WORK SUCCESSFULLY COMPLETED AT CASE LAKE

Major Highlights Results from the world's leading testing, inspection and certification (TIC) company, SGS, confirms outstanding cesium extraction of 97% from the Case Lake pollucite...

Appier Launches AdCreative.ai in Vietnam to Accelerate GenAI-Powered Creatives Transformation for Brands

HO CHI MINH CITY, Vietnam, July 7, 2025 /PRNewswire/ -- Appier (TSE: 4180), an AI-native SaaS company specializing in advanced AdTech and MarTech solutions, officially launches...

Theranos Makes a Big Bang at the FDA

PALM BEACH, Fla., June 27, 2025 (GLOBE NEWSWIRE) -- Today marks a significant milestone for theranos and its diagnostic technology. The theranos system performs automated sample processing and analysis to produce clinical test results. The U.S. Food and Drug Administration’s Center for Devices and Radiological Health (CDRH) has affirmed that the core technology is not under question.

Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt...

BOSTON, June 24, 2025 /PRNewswire/ -- Ascidian Therapeutics, a biotechnology company seeking to treat human diseases by rewriting RNA, today announced the appointment of Murray...

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

Company to also highlight advancements in denials and underpayments management and speak to the measurable impact of RCM technology adoption DENVER, June 22, 2025 /PRNewswire/...

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Next generation analyzer helps hospitals protect revenue before it's lost by delivering timely end-to-end visibility and actionable intelligence DENVER, June 22, 2025 /PRNewswire/ --...

SeAH Aerospace & Defense Receives Boeing’s Supplier Production Partner Award for Excellence in Aerospace Materials

Insta360 Launches Luna Ultra: Leica Co-Engineered Gimbal Camera Built for Next-Generation Mobile Filmmaking

ToolGen Opens Advanced Field Testing Facility in Osong, Completing ‘Bench-to-Field’ Commercialization Platform for Global SAF and Industrial Crop Markets

Tag: analyzer

Bluejay Diagnostics Provides Second Quarter Business and Corporate Update

Pason Reports Second Quarter 2025 Results and Declares Quarterly Dividend

US Air Force Awards Gastops $18.6M Contract for ChipCHECK Oil Debris Analyzers

Biomarkers Market to Grow at a CAGR of 12.3% from 2025 to 2032 | SkyQuest Technology Consulting

FINAL CESIUM TEST WORK SUCCESSFULLY COMPLETED AT CASE LAKE

Appier Launches AdCreative.ai in Vietnam to Accelerate GenAI-Powered Creatives Transformation for Brands

Theranos Makes a Big Bang at the FDA

Ascidian Therapeutics Appoints Dr. Murray A. Abramson as Chief Development Officer and Establishes Ophthalmology Clinical Advisory Board to Advance ACDN-01 for Treatment of Stargardt...

FinThrive Introduces Agentic AI at HFMA 2025 to Help Customers Transform Healthcare Revenue Cycle Management Performance

FinThrive Debuts Denials and Underpayments Analyzer, a Unified Solution for Denials and Underpayments, at HFMA 2025

Explore

Press Releases

News & Opinion

Living

Others

Follow us